Aug 1, 2018 - An electronic calculator has been developed to facilitate increased. Framingham risk score for primary prevention. Files can be down. Framingham-based Tools to Calculate the Global Risk of Coronary Heart Disease. For 1 risk calculator over another, or subjective ease of use.

Welcome to the ASCVD Risk Estimator Plus Terms of Service Click the Terms tab at the bottom of the app before using the ASCVD Risk Estimator Plus (“the Product”) to read the full Terms of Service and License Agreement (the “Agreement”) which governs the use of the Product. The Agreement includes, among other detailed terms and conditions, certain disclaimers of warranties by the American College of Cardiology Foundation (“ACCF”) and requires the user to agree to release ACCF from any and all liability arising in connection with your use of the Product. By using the Product, you accept and agree to be bound by all of the terms and conditions set forth in the Agreement, including such disclaimers and releases. 2013 20 dollar bill serial number. If you do not accept the terms and conditions of the Agreement, you may not proceed to use the Product. The Agreement is subject to change from time to time, and your continued use of the Product constitutes your acceptance of and agreement to be bound by any revised terms of the Agreement. For Optimal Use: • Estimate patient’s 10-year ASCVD risk at an initial visit to establish a reference point. • Forecast the potential impact of different interventions on patient risk.

• Reassess ASCVD risk at follow-up visits. Follow up risk incorporates change in risk factor levels over time and requires both initial and follow up values.

• Use the information above to help with clinician-patient discussions on risk and risk-lowering interventions. See the “About” 'About the App' screen in this app for a definition of terms and additional instructions.

Note: These estimates may underestimate the 10-year and lifetime risk for persons from some race/ethnic groups, especially American Indians, some Asian Americans (e.g., of south Asian ancestry), and some Hispanics (e.g., Puerto Ricans), and may overestimate the risk for others, including some Asian Americans (e.g., of east Asian ancestry) and some Hispanics (e.g., Mexican Americans). Because the primary use of these risk estimates is to facilitate the very important discussion regarding risk reduction through lifestyle change, the imprecision introduced is small enough to justify proceeding with lifestyle change counseling informed by these results. *Start moderate intensity statin, or intensify statin from a moderate to a high intensity dose. **Start blood-pressure lowering medication if not currently taking, or add BP-lowering med (s) to patient’s existing regime. †Stop smoking for two years ǂStart or continue taking aspirin. ¶ NA = Not Applicable. Risk is not shown for therapy(s) that are not recommended.

Guidelines do not recommend statin therapy for patients with 10-year ASCVD risk. AHA/ACC guidelines stress the importance of lifestyle modification as the foundation to lowering cardiovascular disease risk. This includes eating a heart-healthy diet, regular aerobic exercises, maintenance of desirable body weight and avoidance of tobacco products. Supporting Guideline Recommendations Exercise • In general, advise adults to engage in aerobic physical activity to lower BP and/or reduce LDL and non-HDL-C: 3–4 sessions per week, lasting on average 40 min per session, and involving moderate to vigorous-intensity physical activity (IIa, A). For adults with elevated BP or hypertension: • Increased physical activity with a structured exercise program is recommended (I, A). Diet Advise adults who would benefit from BP and/or LDL-C lowering to: • Consume a dietary pattern that emphasizes intake of vegetables, fruits, and whole grains; includes low-fat dairy products, poultry, fish, legumes, nontropical vegetable oils, and nuts; and limits intake of sweets, sugar-sweetened beverages, and red meats (I, A).